Esquire Financial CEO sells 10K shares at $122.73

ESQ’s CEO reported an open-market sale of 10,000 shares and now directly holds 288,798 shares, including several tranches of time-vesting restricted stock.

Rhea-AI Filing Summary

Esquire Financial Holdings, Inc. (ESQ) reports that Vice Chairman, President & CEO Andrew C. Sagliocca sold 10,000 shares of common stock on September 18, 2026 in an open-market transaction at a weighted average price of $122.73 per share, with prices ranging from $122.61 to $123.50.

After this sale, he holds 288,798 shares directly, which include multiple grants of restricted stock scheduled to vest in three equal annual installments beginning on various dates from December 16, 2024 through January 29, 2029. No Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Net Seller: 10,000 shares

Net Sell 1 txn

Insider Sagliocca Andrew C

Role Vice Chairman, President & CEO

Sold 10,000 shs ($1.23M)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2, F3, F4, F5, F6, F7	10,000	$122.73	$1.23M

Holdings After Transaction: Common Stock — 288,798 shares (Direct)

Footnotes (7)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.61 to $123.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
2. F2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.
3. F3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.
4. F4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.
5. F5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.
6. F6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.
7. F7. Includes shares of restricted stock which vest in three equal annual installments commencing on January 29, 2029.

Key Figures

Shares sold: 10,000 shares Weighted average sale price: $122.73 per share Sale price range: $122.61–$123.50 per share +2 more

5 metrics

Shares sold 10,000 shares Common stock sold by the CEO on September 18, 2026

Weighted average sale price $122.73 per share Open-market sale of 10,000 ESQ shares on September 18, 2026

Sale price range $122.61–$123.50 per share Price range for individual trades within the reported sale

Shares owned after transaction 288,798 shares Direct holdings of the CEO following the September 18, 2026 sale

Transaction net buy/sell shares 10,000 shares net sold Net effect of reported Form 4 transactions

Key Terms

weighted average price, restricted stock, vest

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

restricted stock financial

"Includes shares of restricted stock which vest in three equal annual installments"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

vest financial

"restricted stock which vest in three equal annual installments commencing on"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ESQ’s CEO report on this Form 4?

Andrew C. Sagliocca reported a sale of 10,000 shares of Esquire Financial Holdings common stock on September 18, 2026 in an open-market transaction at a weighted average price of $122.73 per share.

What price range did the ESQ shares sell for in the CEO’s September 18, 2026 trade?

The 10,000 ESQ shares were sold at a weighted average price of $122.73, with individual trades executed in a price range from $122.61 to $123.50 per share, according to the footnote disclosure.

How many ESQ shares does the CEO own after the reported sale?

Following the September 18, 2026 sale, Andrew C. Sagliocca directly owns 288,798 shares of Esquire Financial Holdings common stock, including multiple grants of restricted stock that vest in future years.

Are the CEO’s remaining ESQ shares subject to vesting conditions?

Yes. The post-transaction holdings of 288,798 shares include restricted stock that vests in three equal annual installments starting on December 16, 2024, December 9, 2025, December 19, 2026, December 15, 2027, January 30, 2028, and January 29, 2029.

Was the ESQ CEO’s September 2026 stock sale under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that the Rule 10b5-1 checkbox is not marked, and the footnotes do not state that the September 18, 2026 sale was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/21/2026 - 02:07 PM Accepted by SEC EDGAR 09/21/2026 - 02:06 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sagliocca Andrew C

(Last) (First) (Middle)

100 JERICHO QUADRANGLE

SUITE 100

(Street)

JERICHO NEW YORK 11753

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Esquire Financial Holdings, Inc. [ ESQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Vice Chairman, President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/18/2026		S		10,000	D	$122.73(1)	288,798(2)(3)(4)(5)(6)(7)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.61 to $123.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.

2. Includes shares of restricted stock which vest in three equal annual installments commencing on December 16, 2024.

3. Includes shares of restricted stock which vest in three equal annual installments commencing on December 9, 2025.

4. Includes shares of restricted stock which vest in three equal annual installments commencing on December 19, 2026.

5. Includes shares of restricted stock which vest in three equal annual installments commencing on December 15, 2027.

6. Includes shares of restricted stock which vest in three equal annual installments commencing on January 30, 2028.

7. Includes shares of restricted stock which vest in three equal annual installments commencing on January 29, 2029.

	/s/ Eric S. Bader, pursuant to power of attorney	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)